{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T19:48:09Z","timestamp":1782157689176,"version":"3.54.5"},"reference-count":21,"publisher":"American Diabetes Association","issue":"7","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Active Charcot neuroarthropathy (CN) remains difficult to predict. This hypothesis-generating article proposes a deliberately restricted, testable model in which a clinically meaningful fall in HbA1c may temporally coincide with active CN in a subset of people with diabetes, established neuropathy, and a vulnerable foot. The signal is based on a sequence of observations\u2014an initial case report, a 44-case retrospective series, and the EPiChar study\u2014and therefore is supportive of association and biological plausibility, but not causation. Within this framework, osteocalcin should presently be regarded mainly as a candidate biomarker of a transient skeletal activation state rather than a proven pathogenic mediator. This article should therefore be read as a suggestion for prospective testing and not as confirmation of an osteocalcin-mediated pathway. We propose that this systemic signal may intersect with established local drivers\u2014neuropathy, repetitive microtrauma, inflammation, and RANKL\/OPG imbalance\u2014and can be tested prospectively with serial bone turnover markers, neuropathy phenotyping, kidney function, and modifiable exposure data during treatment intensification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Article Highlights<\/jats:title>\n                    <jats:p>Active Charcot neuroarthropathy remains difficult to predict, and its timing is not fully explained by neuropathy and mechanical stress alone. We asked whether a clinically meaningful HbA1c fall may temporally coincide with active Charcot neuroarthropathy and whether osteocalcin could mark transient skeletal vulnerability. Available observations support association and biological plausibility, not causation, and do not prove that osteocalcin is a pathogenic mediator. Prospective monitoring studies are warranted, but current evidence does not justify delaying evidence-based glycemic optimization.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/db26-0064","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:20:09Z","timestamp":1778602809000},"page":"1067-1070","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":0,"title":["Glycemic Improvement and Active Charcot Neuroarthropathy: Osteocalcin as a Candidate Biomarker of Transient Skeletal Vulnerability"],"prefix":"10.2337","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7172-4300","authenticated-orcid":false,"given":"Dured","family":"Dardari","sequence":"first","affiliation":[{"name":"Diabetology Department, Centre Hospitalier Sud Francilien , Corbeil-Essonnes, France"},{"name":"Laboratoire de Biologie de l'Exercice pour la Performance et la Sant\u00e9, Universit\u00e9 d\u2019Evry , L\u2019Institut de Recherche Biom\u00e9dicale des Arm\u00e9es, and Universit\u00e9 \u00c9vry Paris-Saclay, Evry, France"},{"name":"Kremlin Bic\u00eatre Medical School, Universit\u00e9 Paris-Saclay , Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"2026062214523051000_B1","doi-asserted-by":"crossref","first-page":"e3646","DOI":"10.1002\/dmrr.3646","article-title":"Guidelines on the diagnosis and treatment of active Charcot neuro-osteoarthropathy in persons with diabetes mellitus (IWGDF 2023)","volume":"40","author":"Wukich","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"key":"2026062214523051000_B2","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s11892-005-0050-z","article-title":"Theories concerning the pathogenesis of the acute Charcot foot suggest future therapy","volume":"5","author":"Jeffcoate","year":"2005","journal-title":"Curr Diab Rep"},{"key":"2026062214523051000_B3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/dme.12590","article-title":"Inflammatory and bone turnover markers in a cross-sectional and prospective study of acute Charcot osteoarthropathy","volume":"32","author":"Petrova","year":"2015","journal-title":"Diabet Med"},{"key":"2026062214523051000_B4","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.3390\/ijms24033014","article-title":"RANKL-RANK-OPG pathway in Charcot diabetic foot: pathophysiology and clinical-therapeutic implications","volume":"24","author":"Greco","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026062214523051000_B5","doi-asserted-by":"crossref","first-page":"107438","DOI":"10.1016\/j.jdiacomp.2019.107438","article-title":"Multifocal (tarsus and knee) activation of neuroarthropathy following rapid glycaemic correction","volume":"33","author":"Dardari","year":"2019","journal-title":"J Diabetes Complications"},{"key":"2026062214523051000_B6","doi-asserted-by":"crossref","first-page":"e0233168","DOI":"10.1371\/journal.pone.0233168","article-title":"Rapid glycemic regulation in poorly controlled patients living with diabetes, a new associated factor in the pathophysiology of Charcot\u2019s acute neuroarthropathy","volume":"15","author":"Dardari","year":"2020","journal-title":"PLoS One"},{"key":"2026062214523051000_B7","doi-asserted-by":"crossref","first-page":"e002380","DOI":"10.1136\/bmjdrc-2021-002380","article-title":"Trends in the relation between hyperglycemia correction and active Charcot neuroarthropathy: results from the EPICHAR study","volume":"10","author":"Dardari","year":"2022","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2026062214523051000_B8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/brain\/awu307","article-title":"Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes","volume":"138","author":"Gibbons","year":"2015","journal-title":"Brain"},{"key":"2026062214523051000_B9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s002239900498","article-title":"Bone turnover and insulin-like growth factor I levels increase after improved glycemic control in noninsulin-dependent diabetes mellitus","volume":"63","author":"Rosato","year":"1998","journal-title":"Calcif Tissue Int"},{"key":"2026062214523051000_B10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nrendo.2012.201","article-title":"The role of osteocalcin in human glucose metabolism: marker or mediator?","volume":"9","author":"Booth","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"2026062214523051000_B11","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s12020-017-1396-0","article-title":"Insulin and osteocalcin: further evidence for a mutual cross-talk","volume":"59","author":"Bilotta","year":"2018","journal-title":"Endocrine"},{"key":"2026062214523051000_B12","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.4239\/wjd.v15.i9.1858","article-title":"Rapid correction of chronic hyperglycemia and bone remodeling, warning against overdoing","volume":"15","author":"Dardari","year":"2024","journal-title":"World J Diabetes"},{"key":"2026062214523051000_B13","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s40620-017-0408-8","article-title":"Circulating markers of bone turnover","volume":"30","author":"Vervloet","year":"2017","journal-title":"J Nephrol"},{"key":"2026062214523051000_B14","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3390\/medicina58020224","article-title":"The impact of GLP1 agonists on bone metabolism: a systematic review","volume":"58","author":"Daniilopoulou","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"2026062214523051000_B15","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.3389\/fphar.2018.01517","article-title":"Effect of sodium-glucose co-transporter 2 inhibitors on bone metabolism and fracture risk","volume":"9","author":"Ye","year":"2019","journal-title":"Front Pharmacol"},{"key":"2026062214523051000_B16","doi-asserted-by":"crossref","first-page":"522","DOI":"10.7547\/0003-0538-104.5.522","article-title":"The development of a Charcot foot after significant weight loss in people with diabetes: three cautionary tales","volume":"104","author":"Murchison","year":"2014","journal-title":"J Am Podiatr Med Assoc"},{"key":"2026062214523051000_B17","doi-asserted-by":"crossref","first-page":"e928449","DOI":"10.12659\/AOT.928449","article-title":"Why the risk of developing neuroarthropathy is higher after simultaneous kidney and pancreatic transplantation compared to kidney transplantation only: the role of euglycemia","volume":"26","author":"Dardari","year":"2021","journal-title":"Ann Transplant"},{"key":"2026062214523051000_B18","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"key":"2026062214523051000_B19","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Diabetes Control and Complications Trial Research Group","year":"1993","journal-title":"N Engl J Med"},{"key":"2026062214523051000_B20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2337\/dc13-2114","article-title":"Neuropathy and related findings in the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications study","volume":"37","author":"Martin","year":"2014","journal-title":"Diabetes Care"},{"key":"2026062214523051000_B21","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.2337\/dc11-2184","article-title":"Intensive glycemic control is not associated with fractures or falls in the ACCORD randomized trial","volume":"35","author":"Schwartz","year":"2012","journal-title":"Diabetes Care"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/75\/7\/1067\/869034\/db260064.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/75\/7\/1067\/869034\/db260064.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T18:52:41Z","timestamp":1782154361000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/75\/7\/1067\/166969\/Glycemic-Improvement-and-Active-Charcot"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":21,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,5,12]]},"published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db26-0064","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]}}}